Ticker Details
Tango Therapeutics, Inc.
IPO Date:	September 3, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.97B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.33 | 4.21%
Avg Daily Range (30 D):	$1.31 | 5.20%
Avg Daily Range (90 D):	$1.03 | 4.79%

Institutional Daily Volume
Avg Daily Volume:	.96M
Avg Daily Volume (30 D):	4.61M
Avg Daily Volume (90 D):	3.53M

Trade Size
Avg Trade Size (Sh.):	109
Avg Trade Size (Sh.) (30 D):	96
Avg Trade Size (Sh.) (90 D):	95

Institutional Trades
Total Institutional Trades:	1,836
Avg Institutional Trade:	$2.19M
Avg Institutional Trade (30 D):	$3.1M
Avg Institutional Trade (90 D):	$2.74M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$3.37M
Avg Closing Trade (30 D):	$19.87M
Avg Closing Trade (90 D):	$10.76M
Avg Closing Volume:	262.82K

News

Jun 10, 2026 @ 2:49 AM Tango Therapeutics Announces Pricing of $600 Milli... Source: Na

May 30, 2026 @ 12:27 AM Why This Fund Made a $189 Million Bet on Erasca as... Source: Jonathan Ponciano

May 30, 2026 @ 12:21 AM Tango Therapeutics Stock Is Up 840%, and This Fund... Source: Jonathan Ponciano

Mar 19, 2026 @ 3:00 PM The Patent Cliff is Coming, Driving Smart Money To... Source: Equity-Insider.Com

Mar 6, 2026 @ 10:33 PM Tango Therapeutics Announces Inducement Grants Und... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.32	$-.3	$-.87
Diluted EPS	$-.32	$-.3	$-.87
Revenue	$M	$M	$62.38M
Gross Profit
Net Income / Loss	$-45.51M	$-38.75M	$-101.59M
Operating Income / Loss	$-48.77M	$-41.86M	$-111.29M
Cost of Revenue
Net Cash Flow	$45.12M	$53.94M	$42.75M
PE Ratio